BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17352848)

  • 1. Effect of Plasmodium yoelii nigeriensis infection on hepatic and splenic glutathione-S-transferase(s) in Swiss albino and db/+ mice: efficacy of mefloquine and menadione in antimalarial chemotherapy.
    Ahmad R; Srivastava AK
    Parasitology; 2007 Jul; 134(Pt 7):931-8. PubMed ID: 17352848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimalarial efficacy of methylene blue and menadione and their effect on glutathione metabolism of Plasmodium yoelii-infected albino mice.
    Arora K; Srivastava AK
    Parasitol Res; 2005 Dec; 97(6):521-6. PubMed ID: 16217669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis.
    Awasthi A; Dutta GP; Bhakuni V; Tripathi R
    Exp Parasitol; 2004; 107(3-4):115-9. PubMed ID: 15363936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status of hepatic oxidative stress and antioxidant defense systems during chloroquine treatment of Plasmodium yoelii nigeriensis infected mice.
    Siddiqi NJ; Alhomida AS
    In Vivo; 1999; 13(6):547-50. PubMed ID: 10757052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonist effect of chloroquine and tumor necrosis factor on hepatic oxidative stress and antioxidant defense in normal and Plasmodium yoelii nigeriensis-infected mice.
    Siddiqi NJ; Alhomida AS; Dutta GP; Pandey VC
    In Vivo; 2002; 16(1):67-70. PubMed ID: 11980364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clarithromycin, a cytochrome P450 inhibitor, can reverse mefloquine resistance in Plasmodium yoelii nigeriensis- infected Swiss mice.
    Tripathi R; Pandey SK; Rizvi A
    Parasitology; 2011 Aug; 138(9):1069-76. PubMed ID: 21756423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
    Mohd Ridzuan MA; Ruenruetai U; Noor Rain A; Khozirah S; Zakiah I
    Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of poly ICLC treatment on hepatic oxidative stress and antioxidant defense indices in Plasmodium yoelii nigeriensis infected mice.
    Siddiqi NJ; Alhomida AS; Maheshwari RK; Pandey VC
    In Vivo; 2001; 15(1):77-80. PubMed ID: 11286134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys.
    Puri SK; Singh N
    Exp Parasitol; 2000 Jan; 94(1):8-14. PubMed ID: 10631075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on erythrocytic methemoglobin reductase systems in Plasmodium yoelii nigeriensis infected mice.
    Srivastava S; Alhomida AS; Siddiqi NJ
    In Vivo; 2000; 14(4):547-50. PubMed ID: 10945172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chloroquine, methylene blue and artemether on red cell and hepatic antioxidant defence system in mice infected with Plasmodium yoelii nigeriensis.
    Nneji CM; Adaramoye OA; Falade CO; Ademowo OG
    Parasitol Res; 2013 Jul; 112(7):2619-25. PubMed ID: 23604568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium yoelii: influence of antimalarial treatment on acquisition of immunity in BALB/c and DBA/2 mice.
    Ma SH; Zheng L; Liu YJ; Guo SY; Feng H; Chen G; Li DM; Wang JC; Cao YM
    Exp Parasitol; 2007 Jul; 116(3):266-72. PubMed ID: 17336298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimalarial and antioxidant activities of methanolic extract of Nigella sativa seeds (black cumin) in mice infected with Plasmodium yoelli nigeriensis.
    Okeola VO; Adaramoye OA; Nneji CM; Falade CO; Farombi EO; Ademowo OG
    Parasitol Res; 2011 Jun; 108(6):1507-12. PubMed ID: 21153838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on hepatic mitochondrial cytochrome P-450 during Plasmodium yoelii infection and pyrimethamine treatment in mice.
    Srivastava P; Pandey VC
    Ecotoxicol Environ Saf; 2000 May; 46(1):19-22. PubMed ID: 10805988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of glutathione-S-transferase from Plasmodium yoelii by protoporphyrin IX, cibacron blue and menadione: implications and therapeutic benefits.
    Ahmad R; Srivastava AK
    Parasitol Res; 2008 Mar; 102(4):805-7. PubMed ID: 18180958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium yoelii nigeriensis (MDR)-efficacy of oral pyronaridine against multidrug-resistant malaria in Swiss mice.
    Tripathi R; Umesh A; Mishra M; Puri SK; Dutta GP
    Exp Parasitol; 2000 Mar; 94(3):190-3. PubMed ID: 10831384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single dose curative and prophylactic efficacy of antimalarial drugs against multi-resistant Plasmodium yoelii nigeriensis.
    Shukla B; Dutta GP
    J Commun Dis; 1988 Sep; 20(3):175-84. PubMed ID: 3256563
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo antimalarial activity of leaves of Plectranthus amboinicus (lour) spreng on Plasmodium berghei yoelii.
    Periyanayagam K; Nirmala Devi K; Suseela L; Uma A; Ismail M
    J Commun Dis; 2008 Jun; 40(2):121-5. PubMed ID: 19301696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on hepatic oxidative stress and antioxidant defence systems during arteether treatment of Plasmodium yoelii nigeriensis infected mice.
    Siddiqi NJ; Pandey VC
    Mol Cell Biochem; 1999 Jun; 196(1-2):169-73. PubMed ID: 10448917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Cymbopogon giganteus and Enantia chrantha against chloroquine resistant Plasmodium yoelii nigeriensis.
    Kimbi HK; Fagbenro-Beyioku AF
    East Afr Med J; 1996 Oct; 73(10):636-7. PubMed ID: 8997841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.